QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $131K invested in Qualigen Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$100K
2
+$27K

Top Sellers

1
-$34.3K
2
-$3.85K
3
-$2.1K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$13
5
Osaic Holdings
Osaic Holdings
Arizona
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
CBA
1
Coastal Bridge Advisors
Connecticut
$100K
FIA
2
FNY Investment Advisers
New York
$27K
BlackRock
3
BlackRock
New York
$1.86K
TRCT
4
Tower Research Capital (TRC)
New York
$1.36K
HWM
5
HighMark Wealth Management
Minnesota
$582
Bank of America
6
Bank of America
North Carolina
$80
Group One Trading
7
Group One Trading
Illinois
$29
US Bancorp
8
US Bancorp
Minnesota
$25
PWA
9
Physician Wealth Advisors
Utah
$8
SS
10
SBI Securities
Japan
$4
Morgan Stanley
11
Morgan Stanley
New York
–
UBS Group
12
UBS Group
Switzerland
–
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
–
Osaic Holdings
14
Osaic Holdings
Arizona
–